Randomized Double-Blind, Placebo-Controlled Feasibility Study, Evaluating the Efficacy of Homeopathic Medicines in the Prevention of COVID-19 in a Quarantined Population

Introduction - Exploring preventive therapeutic measures has been among the biggest challenges during the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We explored the feasibility and methods of recruitment, retention, and potential signal of efficacy, of selected homeopathic medicines as preventive measure for developing COVID-19 in a multi-group study. Methods - A six-group, randomized, double-blind, placebo-controlled prophylaxis study was conducted in a COVID-19 exposed population in a quarantine facility in Mumbai, India. Each group received one of the following: Arsenicum album 30c, Bryonia alba 30c, a combination (Arsenicum album 30c, Bryonia alba 30c, Gelsemium sempervirens 30c, and Influenzinum 30c), coronavirus nosode CVN01 30c, Camphora 1M, or placebo. Six pills twice a day were administered for 3 days. The primary outcome measure used was testing recruitment and retention in this quarantined setting. Secondary outcomes were numbers testing positive for COVID-19 after developing symptoms of illness, number of subjects hospitalized, and days to recovery. Results - Good rates of recruitment and retention were achieved. Of 4,497 quarantined individuals, 2,343 sought enrollment, with 2,294 enrolled and 2,233 completing the trial (49.7% recruitment, 97.3% retention). Subjects who were randomized to either Bryonia alba or to the CVN01 nosode signaled (p <0.10) a lower incidence of laboratory-confirmed COVID-19 and a shorter period of illness, with evidence of fewer hospitalizations, than those taking placebo. The three other groups did not show signals of efficacy. Conclusion - This pilot study supports the feasibility of a larger randomized, double-blind, placebo-controlled trial. Bryonia alba 30c and CVN01 30c should both be explored in disease prevention or shortening the course of disease symptomatology in a COVID-19-exposed population.

Lascia un commento

https://anzionettuno.cri.it/ https://comitatocotronei.cri.it/ https://vuck.ec/ https://perugia.cri.it/ https://savigliano.cri.it/ https://floridia.cri.it/ https://monopoli.cri.it/ https://creatour.id/ https://grupoesferavet.com/ https://bagnoaripoli.cri.it/ https://kamanta.it/ https://clinicajesusdenazareth.com/ https://junglecitystudios.com/ https://chiaraasoli.it/ https://www.semgiron.org/ https://comitatosassari.cri.it/ https://baccar-group.com/ slot gacor https://innovapyc.com/ https://menaggio.cri.it/ https://crireggiocalabria.cri.it/ https://perfect-logistic.com/ https://pgmi.tarbiyah.iainfmpapua.ac.id/
https://law.dme.ac.in/
https://privet-alice.ru/
https://societyon.tv/
https://www.ptjmi.co.id/wp-includes/toto/
https://www.ptjmi.co.id/wp-content/themes/xia/
https://www.ptjmi.co.id/wp-content/plugins/chin/
https://www.ptjmi.co.id/wp-content/uploads/2022/
https://www.ptjmi.co.id/wp-includes/css/sv388/
https://pratamaindonesia.co.id/htdocs/sd/
https://www.ptjmi.co.id/wp-includes/reners/
Kudaemas88 Kudaemas88 xlbola cantik555 cantik555 cantik555 slot mahjong cantik555 cantik555 https://societyon.tv/ https://kindpak.com/
slot gacor